QA: Keenova Therapeutics plc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001567892_2025_Keenova_Therapeutics_plc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001567892, Keenova Therapeutics plc

  xvar xval
0 AssetsCurrent 1,629,100,000
1 IntangibleAssetsNetIncludingGoodwill 419,400,000
2 PropertyPlantAndEquipmentNet 390,600,000
3 remainder_Assets 863,500,000
4 LiabilitiesCurrent 431,400,000
5 LiabilitiesNoncurrent 102,900,000
6 remainder_Liabilities 1,122,500,000
7 CostOfGoodsAndServicesSold 1,152,600,000
8 SellingGeneralAndAdministrativeExpense 566,800,000
9 ResearchAndDevelopmentExpense 115,700,000
10 remainder_Expenses 376,700,000
11 remainder_Revenues 1,979,700,000
12 remainder_NetIncome 19,200,000
13 remainder_ComprehensiveNetIncome 2,500,000
  yvar yval
0 Assets 3,302,600,000
1 Liabilities 1,656,800,000
2 Expenses 2,211,800,000
3 Revenues 1,979,700,000
4 StockholdersEquity 1,645,800,000
5 NetIncome -212,900,000
6 ComprehensiveNetIncome -211,650,000
7 BaseVar 4,586,300,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.36
9 EconomicCapitalRatio 2.58

Edgar->Model Mapping

Feature Distribution

Change over Time